As tomorrow’s innovations are developed by today’s entrepreneurs, we strategically invest in transformational scientific opportunities to augment our core R&D interests and gain access to next-generation science and proven scientific leaders.
We’re AbbVie’s Corporate Strategic Venture Capital Arm
AbbVie Ventures represents a core component of our integrated approach to external innovation. We invest globally in early stage transformational life sciences companies that augment our core R&D areas within oncology, autoimmune/inflammatory diseases, neurodegenerative diseases and hepatology.
We build strong relationships with fellow investors, entrepreneurs and industry experts, which provides us insights into novel technologies and biology as well as early exposure to potential business development opportunities. Our expertise in drug discovery, development and commercialization serves as a valuable resource to our portfolio companies. While our Ventures team is located at AbbVie headquarters in North Chicago, Boston/Cambridge and the San Francisco Bay area, we invest in opportunities generated across the United States, Canada and Europe.
Scott Brun, VP and Head, AbbVie Ventures
Margarita Chavez, Chicago and San Francisco area
Jay Cui, Chicago area
John Gustofson, Boston/Cambridge area
Chuck Kunsch, Boston/Cambridge area
Ross Leimberg, Boston/Cambridge area
KT Moortgat, San Francisco area
Priyanka Rohatgi, Chicago area